Memorial Hermann Advantage HMO February 2019 Formulary Addendum

Similar documents
2019 Formulary Update

Health Partners Medicare Prime 2019 Formulary Changes

Notice of Mid-Year Changes to 2019 Paramount Enhanced Formulary

2018 CareOregon Advantage Part D Formulary Changes

2018 Step Therapy (ST) Criteria

2016 Step Therapy (ST) Criteria

2017 Formulary Addendum Notice of Change (Medicare Advantage Plans)

Alprazolam 0.25mg, 0.5mg, 1mg tablets

2015 Step Therapy (ST) Criteria

2017 Formulary Addendum Notice of Change (Medicare Advantage Plans)

2014 Step Therapy Criteria (List of Step Therapy Criteria)

2017 Formulary Addendum Notice of Change

Acyclovir Ointment. Aetna Better Health Pennsylvania. Products Affected. acyclovir ointment 5 % external Details. Criteria

2017 Formulary Addendum Notice of Change (Prescription Drug Plans)

ANTIDEPRESSANTS. Details. Step Therapy 2018 Last Updated: 8/21/2018

2017 Formulary Addendum Notice of Change

2017 Formulary Addendum Notice of Change (Medicare Advantage Plans)

2017 Medicare Part D Formulary Change

PPHP 2017 Formulary 2017 Step Therapy Criteria

You ll find the most up-to-date comprehensive version of our formulary on our website, Click on Drug Finder.

ARISTADA. Products Affected Step 2: ARISTADA PREFILLED SYRINGE 1064 MG/3.9ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 441 MG/1.

CARE N CARE HEALTH PLAN

2017 Formulary Addendum Notice of Change

ANTIDEPRESSANTS. Details. Step Therapy 2017 Last Updated: 5/23/2017

CARE N CARE HEALTH PLAN

WellCare s South Carolina Preferred Drug List Update

WellCare Signature (PDP) and WellCare Classic (PDP) Formulary Addendum

2019 Drug List Negative Changes

2018 Formulary Update

Quarterly pharmacy formulary change notice

2019 Drug List Negative Changes

Y0133_StepTherapyCriteria _C 10/18/18 Y0133_StepTherapyCriteria _C es 10/18/18

Superior Select Health Plans: Tribute-1 Tier May 2018 Formulary Addendum

Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates

2014 Quantity Limits (QL) Criteria

2016 FORMULARY ADDENDUM NOTICE OF CHANGE

NOTIFICATION OF FORMULARY CHANGES

September 2018 Pharmacy & Therapeutics Committee Decisions

Partners Notice of Change March 2017

Mercy Care Plan. Acyclovir Ointment. Products Affected. acyclovir ointment 5 % external Details. Criteria. Requires use of oral Acyclovir

Drugs That Require Step Therapy (ST)

2018 Formulary Notice of Change Prescription Drug Plans

Kansas Health Advantage (HMO SNP) 2018 Formulary Quantity Limit Criteria

DIFICID. Products Affected Step 2: DIFICID TABLET 200 MG ORAL. Details

Drugs That Require Step Therapy (ST)

Drugs That Require Step Therapy (ST)

Formulary (Drug List)

HEALTHTEAM ADVANTAGE 2018 Step Therapy Criteria

CARE N CARE HEALTH PLAN

Medicare Part D 2016 Formulary Changes Service To Senior and OC Preferred

HEALTHTEAM ADVANTAGE 2018 Step Therapy Criteria

APREPITANT ARMODAFINIL BELSOMRA BUPAP BUPRENORPHINE HCL BUTALBITAL-ACETAMINOPHEN BUTALBITAL-APAP-CAFF-COD BUTALBITAL-APAP-CAFFEINE

Peach State Health Plan routinely reviews the medications available on the Preferred Drug

Step Therapy Criteria

PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary April 1, 2018 Updates. Formulary Alternatives

Aetna Better Health Illinois Premier Plan. November 2015 Formulary Updates. October 2015 Formulary Updates

HEALTH SHARE/PROVIDENCE (OHP)

These programs and quantity limitations may not apply. Check your certificate or other plan information for benefit details.

ANTICONVULSANTS. Details. Step Therapy Criteria Date Effective: April 1, 2019

Aetna Better Health of Illinois Medicaid Formulary Updates

2018 Medicare Part D Formulary Change

Medicare Part D Drugs that Require Step Therapy Effective 12/01/2017

ABILIFY INJ. Products Affected Step 2: ABILIFY MAINTENA PREFILLED SYRINGE 300 MG INTRAMUSCULAR ABILIFY MAINTENA PREFILLED SYRINGE 400 MG INTRAMUSCULAR

Pharmacy Updates Summary

Tribute 2018 Formulary 2018 Quantity Limit Criteria

WellCare s South Carolina Preferred Drug List Update

Changes to the 2018 BlueCross Secure SM (HMO) & BlueCross Total SM (PPO) Formularies

2017 Medicare Part D Formulary Change

2018 Medicare Part D Formulary Change

2017 Formulary Changes Year to Date

Quarterly pharmacy formulary change notice

Mercy Care ALBENDAZOLE. Products Affected. ALBENZA TABLET 200 MG ORAL Details. Criteria. Refer to PA Guideline for approval criteria

Quarterly pharmacy formulary change notice

The following list of recommended PDL changes were reviewed and approved by the MHS P&T Committee on December 14 th, 2016.

Allergan s Blephamide (sulfacetamide/prednisolone ophthalmic ointment) 10%/0.2%, 3.5Gm tube

Neighborhood Medicaid Formulary Changes: June 2017

Tribute 2018 Formulary 2018 Quantity Limit Criteria

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Golden State Medicare Health Plan, Golden (HMO) Last Updated: 09/01/2018

PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary April 1, 2018 Updates. Formulary Alternatives

Health Partners Medicare Special 2018 Formulary Changes

Pharmacy Formulary Updates for January 2019

Step Therapy Requirements. Effective: 11/01/2018

UPDATE Ohana QUEST Integration Medicaid

Emblem Medicaid 3Q18 Formulary Updates

Aetna Better Health FIDA Plan

5-ASA. Products Affected DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED RELEASE. Details

5-ASA. Products Affected. Details. Dipentum 250 mg capsule. Lialda 1.2 gram tablet,delayed release

Additional drug coverage

MEDICARE Program Policies & Procedures POLICY NUMBER: Medicare D-111

Plan Year CCHP Senior Program (HMO) Step Therapy Criteria (ST)

PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES

Advance Notification of Amendments to the December 2018 Drug Tariff

Transcription:

Memorial Hermann Advantage HMO February 2019 Formulary Addendum Changes may have occurred since the printing of your current Memorial Hermann Advantage HMO Formulary. Medications that may have been added or removed from the Formulary are listed below. Please retain this with your copy of the Formulary. This is not a complete list of drugs covered by our plan. For a complete listing or other questions, please call Customer Service at 844-860-6750 (TTY users call 711), 24 hours a day, seven (7) days a week or visit healthplan.memorialhermann.org/medicare. The Formulary may change at any time. You will receive notice when necessary. You must generally use network pharmacies to use your prescription drug benefit. Benefits, formulary, pharmacy network, and/or copayments/coinsurance may change on January 1, 2019, and from time to time during the year. Memorial Hermann Advantage HMO is provided by Memorial Hermann Health Plan, Inc., a Medicare Advantage organization with a Medicare contract. Enrollment in this plan depends on contract renewal. BvD May be covered under Medicare Part B or D depending upon the circumstances; Non-Formulary; PA Prior Authorization; QL Quantity Limit, dispense limit for 30 days unless otherwise noted; ST Step Therapy; LA Limited Access (This prescription may be available only at certain pharmacies), EFFECTIVE 01/01/2019 Auryxia TABLET 1 GM 210 MG(Fe) 4 4 + PA1 N/A BromSite SOLUTION 0.075 % OPHTHALMIC 4 Cimduo Tablet 300-300 MG 5 Estropipate TABLET 1.5 MG 1 CMS Required Deletion N/A Page 1 of 6

Humira Pen-CD/UC/HS Starter Pen- Injector Kit 80 MG/0.8ML Subcutaneous Humira Pen-Ps/UV Starter Pen-Injector Kit 80 MG/0.8ML & 40MG/0.4ML, 5 + PA1 5 + PA1 Subcutaneous Incassia Tablet 0.35 MG 1 Ketoprofen CAPSULE 75 MG 2 CMS Required Deletion N/A Trelegy Ellipta Aerosol Powder Breath Activated 100-62.5-25 MCG/INH Inhalation 3 + ST1 Vestura TABLET 3-0.02 MG 2 CMS Required Deletion N/A Xeljanz Tablet 10 MG 5 + PA1 RELEASE PARTICLES 15000 UNIT Zenpep Capsule Delayed Release Particles 15000-47000 UNIT RELEASE PARTICLES 25000 UNIT RELEASE PARTICLES 3000-10000 UNIT Zenpep Capsule Delayed Release Particles 3000-14000 UNIT RELEASE PARTICLES 5000 UNIT EFFECTIVE 02/01/2019 Abiraterone Acetate Tablet 250 MG 3 3 5 + QL 120 + Adapalene Solution 0.1 % External 4 + PA1 Afeditab CR Tablet Extended Release 24 Hour 60 MG 1 CMS Required Deletion N/A Ampyra Tablet Extended Release 12 Hour 10 MG 5 + QL 60 + + LA dalfarmpridine 10mg, 5 + QL 60 + Page 2 of 6

AndroGel GEL 20.25 MG/1.25GM (1.62%) TRANSDERMAL AndroGel GEL 40.5 MG/2.5GM (1.62%) TRANSDERMAL AndroGel Pump GEL 20.25 MG/ACT (1.62%) TRANSDERMAL 3 + 3 + 3 +, testosterone 0.0162mg/mg, 3 + testosterone 0.0162mg/mg, 3 + testosterone 20.25mg/actua, 3 + Arikayce Suspension 590 MG/8.4ML Inhalation 2 + PA1 Azelaic Acid Gel 15 % External 4 Braftovi Capsule 50 MG 5 + + LA Braftovi Capsule 75 MG 5 + + LA BuPROPion HCl ER (XL) Tablet Extended Release 24 Hour 450 MG Cefotaxime Sodium Solution Reconstituted 2 GM Injection Clinimix/Dextrose (2.75/5) SOLUTION 2.75 % Intravenous Clinimix/Dextrose (4.25/20) SOLUTION 4.25 % Intravenous CloBAZam Suspension 2.5 MG/ML 4 + QL 30 + ST2 Formulary Enhancement N/A 2 CMS Required Deletion N/A 4 + BvD CMS Required Deletion N/A 4 + BvD CMS Required Deletion N/A 4 + CloBAZam Tablet 10 MG 4 + QL 60 + CloBAZam Tablet 20 MG 4 + QL 60 + Colesevelam HCl Packet 3.75 GM 3 Copiktra Capsule 15 MG 5 + QL 60 + + LA Copiktra Capsule 25 MG 5 + QL 60 + + LA Cyred EQ Tablet 0.15-30 MG-MCG 1 DAPTOmycin Solution Reconstituted 350 MG Intravenous 4 + PA1 Delstrigo Tablet 100-300-300 MG 5 Page 3 of 6

, Epidiolex Solution 100 MG/ML 4 + Ertapenem Sodium Solution Reconstituted 1 GM Injection 4 Finacea GEL 15 % EXTERNAL 4 azelaic acid 0.15mg/mg, 4 bupropion Forfivo XL Tablet Extended Release 24 4 + QL 30 hydrochloride Hour 450 MG + ST2 450mg, 4 + QL 30 + ST2 Hexalen CAPSULE 50 MG 5 + CMS Required Deletion N/A INVanz Solution Reconstituted 1 GM Injection 4 Itraconazole Solution 10 MG/ML 4 + PA1 Ketoprofen Capsule 25 MG 2 Kimidess Tablet 0.15-0.02/0.01 MG ertapenem 1000mg, 4 2 CMS Required Deletion N/A (21/5) Lenvima 12 MG Daily Dose Capsule Therapy Pack 4 (3) MG 5 + Lenvima 4 MG Daily Dose Capsule Therapy Pack 4 MG 5 + Lorbrena Tablet 100 MG 5 + Lorbrena Tablet 25 MG 5 + Mektovi Tablet 15 MG 5 + + LA Molindone HCl Tablet 10 MG 2 Molindone HCl Tablet 25 MG 2 Molindone HCl Tablet 5 MG 2 Morphine Sulfate ER Capsule Extended Release 24 Hour 40 MG 2 Nafcillin Sodium Solution Reconstituted 2 GM Injection 2 Necon 7/7/7 Tablet 0.5/0.75/1-35 MG- MCG 1 CMS Required Deletion N/A Norvir CAPSULE 100 MG 4 CMS Required Deletion N/A Onfi SUSPENSION 2.5 MG/ML Onfi TABLET 10 MG 5 + 4 + QL 60 + clobazam 2.5mg/ml, 4 + clobazam 10mg, 4 + QL 60 + Page 4 of 6

Onfi TABLET 20 MG 5 + QL 60 +, clobazam 20mg, 4 + QL 60 + Orilissa Tablet 150 MG 5 + PA1 Orilissa Tablet 200 MG 5 + PA1 Orkambi Packet 100-125 MG 5 + PA1 + LA Orkambi Packet 150-188 MG 5 + PA1 + LA Periogard Solution 0.12 % Mouth/Throat 2 CMS Required Deletion N/A Pifeltro Tablet 100 MG 5 Sodium Chloride Solution 2.5 MEQ/ML Injection 2 CMS Required Deletion N/A Symtuza Tablet 800-150-200-10 MG 5 Takhzyro Solution 300 MG/2ML Subcutaneous 5 + PA1 + LA Talzenna Capsule 0.25 MG 5 + + LA Talzenna Capsule 1 MG 5 + + LA Testosterone Gel 20.25 MG/1.25GM 3 + (1.62%) Transdermal Testosterone Gel 20.25 MG/ACT (1.62%) Transdermal 3 + Testosterone Gel 40.5 MG/2.5GM (1.62%) Transdermal 3 + Tibsovo Tablet 250 MG 5 + + LA Tiglutik Suspension 50 MG/10ML 4 + PA1 Triamcinolone Acetonide Aerosol 55 MCG/ACT Nasal 2 CMS Required Deletion N/A Vancomycin HCl Solution Reconstituted 250 MG Intravenous 2 + BvD Versacloz Suspension 50 MG/ML 5 + ST2 CMS Required Deletion N/A Vizimpro Tablet 15 MG 5 + QL 30 + Vizimpro Tablet 30 MG 5 + QL 30 + Vizimpro Tablet 45 MG 5 + QL 30 + Page 5 of 6

, Welchol Packet 3.75 GM 3 colesevelam hydrochloride 3750mg, 2 Xarelto Tablet 2.5 MG 3 Xofluza Tablet Therapy Pack 20 (2) MG 4 + QL 2/365 Xofluza Tablet Therapy Pack 40 (2) MG 4 + QL 2/365 Xolair Solution Prefilled Syringe 150 5 + QL 6/28 + MG/ML Subcutaneous PA1 + LA Xolair Solution Prefilled Syringe 75 5 + QL 6/28 + MG/0.5ML Subcutaneous PA1 + LA Zortress Tablet 1 MG 5 + Zytiga TABLET 250 MG 5 + QL 120 + abiraterone acetate 250mg, 5 + QL 120 + Page 6 of 6